Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL607400 (UCB-34714, UCB 34714, Briviact, Brivaracetam) |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
synaptic vesicle glycoprotein 2A/Synaptic vesicle protein 2a in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4381] [GtoPdb: 2634] [UniProtKB: Q02563] | ||||||||
ChEMBL | Displacement of [3H]-2-[4-(3-azidophenyl)-2-oxo-1-pyrrolidinyl]butanamide from SV2A levetiracetam binding site in Sprague-Dawley rat cerebral cortex membranes after 120 mins by liquid scintillation counting method | B | 6 | pKi | <=1000 | nM | Ki | EP-1452524-A1. 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses (2004) |
GtoPdb | In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding site, in rat brain homogenate. | - | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2004) 47: 530-49 [PMID:14736235] |
ChEMBL data shown on this page come from version 28:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]